Spots Global Cancer Trial Database for mitotane
Every month we try and update this database with for mitotane cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma | NCT05344027 | Adrenocortical ... | Mitotane | 19 Years - 85 Years | King's College Hospital NHS Trust | |
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence | NCT03583710 | ENSAT Stage I A... ENSAT Stage II ... ENSAT Stage III... | Cisplatin Etoposide Mitotane Quality-of-Life... | 18 Years - | M.D. Anderson Cancer Center | |
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | NCT00094497 | Carcinoma, Adre... | Etoposide Doxorubicin Cisplatin Streptozotocin Mitotane | 18 Years - | Collaborative Group for Adrenocortical Carcinoma Treatment | |
A Safety and Feasibility Study of Mitotane in Prostate Cancer | NCT02057237 | Prostate Cancer | Mitotane | 18 Years - | University Health Network, Toronto | |
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | NCT00304070 | Stage I Adrenal... Stage II Adrena... Stage III Adren... Stage IV Adrena... | Cisplatin Conventional Su... Doxorubicin Hyd... Etoposide Filgrastim Mitotane Pegfilgrastim | - 21 Years | Children's Oncology Group | |
Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma | NCT05634577 | Adrenocortical ... | Mitotane Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | NCT00304070 | Stage I Adrenal... Stage II Adrena... Stage III Adren... Stage IV Adrena... | Cisplatin Conventional Su... Doxorubicin Hyd... Etoposide Filgrastim Mitotane Pegfilgrastim | - 21 Years | Children's Oncology Group | |
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | NCT00304070 | Stage I Adrenal... Stage II Adrena... Stage III Adren... Stage IV Adrena... | Cisplatin Conventional Su... Doxorubicin Hyd... Etoposide Filgrastim Mitotane Pegfilgrastim | - 21 Years | Children's Oncology Group | |
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery | NCT00778817 | Recurrent Adren... Stage III Adren... Stage IV Adreno... | IMC-A12 mitotane | 18 Years - | National Cancer Institute (NCI) | |
Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients | NCT03083834 | Adrenal Insuffi... Adrenal Cancer | Cosyntropin sti... | 18 Years - 80 Years | Bnai Zion Medical Center |